A novel NFKB2 mutation in a Chinese patient with DAVID syndrome

被引：5
|
作者：
Xiao, Bing [1 ,2 ]
Fang, Di [1 ,2 ]
Liu, Huili [1 ,2 ]
Wang, Lili [1 ,2 ]
Qiu, Wenjuan [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai, Peoples R China
[2] Shanghai Inst Pediat Res, Shanghai, Peoples R China
来源：
GENE | 2019年 / 687卷
关键词：
NF-KAPPA-B; CELL CYTOTOXIC ACTIVITY; DEFICIENCY;
D O I：
10.1016/j.gene.2018.12.050
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：319 / 322
页数：4
相关论文
共 50 条
  • [31] Myc suppression of Nfkb2 accelerates lymphomagenesis
    Keller, Ulrich
    Huber, Juergen
    Nilsson, Jonas A.
    Fallahi, Mohammad
    Hall, Mark A.
    Peschel, Christian
    Cleveland, John L.
    BMC CANCER, 2010, 10
  • [32] Novel Heterozygous Mutation in NFKB2 Is Associated With Early Onset CVID and a Functional Defect in NK Cells Complicated by Disseminated CMV Infection and Severe Nephrotic Syndrome
    Aird, Alejandra
    Lagos, Macarena
    Vargas-Hernandez, Alexander
    Posey, Jennifer E.
    Coban-Akdemir, Zeynep
    Jhangiani, Shalini
    Mace, Emily M.
    Reyes, Anaid
    King, Alejandra
    Cavagnaro, Felipe
    Forbes, Lisa R.
    Chinn, Ivan K.
    Lupski, James R.
    Orange, Jordan S.
    Cecilia Poli, Maria
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [33] Complete deletion of NFKB2: a case report
    Roa-Bautista, A.
    Bustamante, A.
    Izquierdo-Cuervo, S.
    Cifrian, J.
    Ocejo-Vinjals, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 130 - 130
  • [34] A novel mutation of the WRN gene in a Chinese patient with Werner syndrome
    Zhao, N.
    Hao, F.
    Qu, T.
    Zuo, Y. -G.
    Wang, B-X.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (03) : 278 - 281
  • [35] Identification of a novel XK mutation in a Chinese patient with McLeod Syndrome
    Ma, J.
    Liu, Y. M.
    MOVEMENT DISORDERS, 2020, 35 : S29 - S29
  • [36] A Nonsense N -Terminus NFKB2 Mutation Leading to Haploinsufficiency in a Patient with a Predominantly Antibody Deficiency (vol 82, pg 613, 2020)
    Kuehn, Hye Sun
    Bernasconi, Andrea
    Niemela, Julie E.
    Almejun, Maria Belen
    Gallego, William Alexander Franco
    Goel, Shubham
    Stoddard, Jennifer L.
    Sanchez, Ronald Guillermo Pelaez
    Franco, Carlos Andres Arango
    Oleastro, Matias
    Grunebaum, Eyal
    Ballas, Zuhair
    Cunningham-Rundles, Charlotte
    Fleisher, Thomas A.
    Franco, Jose Luis
    Danielian, Silvia
    Rosenzweig, Sergio D.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (08) : 1102 - 1102
  • [37] Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient
    Danandeh, Khashayar
    Jabbari, Parnian
    Rayzan, Elham
    Zoghi, Samaneh
    Shahkarami, Sepideh
    Heredia, Raul Jimenez
    Krolo, Ana
    Shamsian, Bibi Shahin
    Boztug, Kaan
    Rezaei, Nima
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (10) : 1040 - 1046
  • [38] Novel NFKB2 Pathogenic Variants in Two Unrelated Patients with Common Variable Immunodeficiency
    Sundaram, Kruthika
    Ferro, Micol
    Hayman, Grant
    Ibrahim, Mohammad A. A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1159 - 1164
  • [39] Novel NFKB2 Pathogenic Variants in Two Unrelated Patients with Common Variable Immunodeficiency
    Kruthika Sundaram
    Micol Ferro
    Grant Hayman
    Mohammad A. A. Ibrahim
    Journal of Clinical Immunology, 2023, 43 : 1159 - 1164
  • [40] Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype
    Guo, X.
    Koff, J. L.
    Moffitt, A. B.
    Cinar, M.
    Ramachandiran, S.
    Chen, Z.
    Switchenko, J. M.
    Mosunjac, M.
    Neill, S. G.
    Mann, K. P.
    Bagirov, M.
    Du, Y.
    Natkunam, Y.
    Khoury, H. J.
    Rossi, M. R.
    Harris, W.
    Flowers, C. R.
    Lossos, I. S.
    Boise, L. H.
    Dave, S. S.
    Kowalski, J.
    Bernal-Mizrachi, L.
    ONCOGENE, 2017, 36 (29) : 4224 - 4232
12345